Exelon Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Exelon, Lowers Price Target to $39
Morgan Stanley Adjusts Exelon Price Target to $39 From $41
Exelon (EXC) Receives a Buy From Barclays
Exelon Analyst Ratings
Morgan Stanley Adjusts Price Target on Exelon to $41 From $38, Keeps Equalweight Rating
Exelon (EXC) Receives a Rating Update From a Top Analyst
RBC Adjusts Price Target on Exelon to $41 From $37, Keeps Sector Perform Rating
Exelon (EXC) Receives a Buy From BMO Capital
Bank of Montreal, Canada: Maintaining the Exelon (EXC.US) rating, adjusted from superior to superior market rating, target price adjusted from $40.00 to $42.00.
Exelon Analyst Ratings
BMO Capital Maintains Outperform on Exelon, Raises Price Target to $42
Wells Fargo Adjusts Price Target on Exelon to $40 From $39
KeyBanc Remains a Hold on Exelon (EXC)
Scotiabank: Maintaining the Exelon (EXC.US) rating, adjusted from being equal to the general market to being equal to the general market, and the target price was adjusted from $39.00 to $37.00.
Exelon Analyst Ratings
Exelon Analyst Ratings
Barclays Keeps Their Buy Rating on Exelon (EXC)
RBC Capital Reaffirms Their Hold Rating on Exelon (EXC)
Exelon Receives Confident Buy Rating Amidst Strong Q4 Earnings and Proactive Financial Strategy